The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Abstract Epilepsy is a neurological disorder that affects approximately 50 million people worldwide. There is currently no definitive epilepsy cure.…
Abstract Epilepsy is a neurological disorder that affects approximately 50 million people worldwide. There is currently no definitive epilepsy cure.…
Abstract Cannabis use has become increasingly common in the U.S. in recent years, with legalization for medical and recreational purposes…
Abstract In mammals, the transient receptor potential (TRP) channels family consists of six different families, namely TRPC (canonical), TRPV (vanilloid),…
Abstract Background and Objectives: Among HIV infection symptoms, sensory neuropathy (HIV-SN) remains a main cause of suffering, with incidence varying…
Abstract Cannabis sativa L. is a plant long used for its textile fibers, seed oil, and oleoresin with medicinal and…
Abstract Fatigue is a burdensome, multidimensional, and multifactorial symptom that is associated with a wide array of chronic illnesses, specifically…
Abstract Endocannabinoid system consists of cannabinoid type 1 (CB1) and cannabinoid type 2 (CB2) receptors, their endogenous ligands, and the…
Abstract The cannabinoid receptor type 1 (CB1R), a G protein-coupled receptor (GPCR), plays an essential role in the control of…
Abstract At the European Society of Cardiology (ESC) congress of this year 2019, held in Paris from August 31st to…
Abstract Nitrogen (N) availability represents one of the most critical factors affecting cultivated crops. N is indeed a crucial macronutrient…